Physical Activity Level During Pregnancy (Fit4Two)

December 7, 2023 updated by: University Medicine Greifswald

Fit for Two - A Pilot Study on Physical Activity Levels During Pregnancy

This study examines (1) the extent and intensity of physical activity among women in different phases of their pregnancy and (2) the relationship between patterns of physical activity in pregnancy and well-being.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This study examines physical activity in different phases of pregnancy using accelerometry. The recruitment of pregnant women (N=30) in the first or second trimester (until week 23) will be realized over different channels (e.g, local newspapers, facebook, and leaflets in gynecological practices, shopping centers, and nurseries).

Informed consent consists of: (i) activity recording over seven consecutive days using an accelerometer, (ii) completion of standardized questionnaires, (iii) participation in a cardiac ultrasound examination in the German Center for Cardiovascular Research (DZHK) - examination center.

Participants are asked to wear an accelerometer at daytime, and over seven consecutive days, in trimester 1 (week 9-12), trimester 2 (week 23-26), and trimester 3 (week 36-39). Women who are attended the study in the first trimester wear the device up to three time whereas those who are attended the study in their second trimester wear the device up to twice. At the end of each measurement period women are invited to fill in a self-administered questionnaire. Also they are invited to participate in a cardiac ultrasound examination. Optionally, participants may receive feedback on their physical activity measured by accelerometer as well as about results of cardiac ultrasound examination upon completion of the study.

Study Type

Observational

Enrollment (Actual)

36

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Greifswald, Germany, 17475
        • University Medicine Greifswald

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Convenience Sample (female only)

Description

Inclusion Criteria:

- current pregnancy, until pregnancy week 23

Exclusion Criteria:

  • cognitive impairment
  • insufficient language skills

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Extent and intensity of physical activity between pregnancy week 9 and 12
Time Frame: between pregnancy week 9 and 12
Assessement via accelerometry
between pregnancy week 9 and 12
Extent and intensity of physical activity between pregnancy week 23 and 26
Time Frame: between pregnancy week 23 and 26
Assessement via accelerometry
between pregnancy week 23 and 26
Extent and intensity of physical activity between pregnancy week 36 and 39
Time Frame: between pregnancy week 36 and 39
Assessement via accelerometry
between pregnancy week 36 and 39

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Well-being
Time Frame: between pregnancy week 9 and 12
Assessement via self-administered questionnaire: The World Health Organisation- Five Well-Being Index (WHO-5),The total raw score, ranging from 0 to 25, is multiplied by 4 to give the final score, with 0 representing the worst imaginable well-being and 100 representing the best imaginable well-being.
between pregnancy week 9 and 12
Well-being
Time Frame: between pregnancy week 23 and 26
Assessement via self-administered questionnaire: The World Health Organisation- Five Well-Being Index (WHO-5),The total raw score, ranging from 0 to 25, is multiplied by 4 to give the final score, with 0 representing the worst imaginable well-being and 100 representing the best imaginable well-being.
between pregnancy week 23 and 26
Well-being
Time Frame: between pregnancy week 36 and 39
Assessement via self-administered questionnaire: The World Health Organisation- Five Well-Being Index (WHO-5),The total raw score, ranging from 0 to 25, is multiplied by 4 to give the final score, with 0 representing the worst imaginable well-being and 100 representing the best imaginable well-being.
between pregnancy week 36 and 39
Mother-child bond
Time Frame: between pregnancy week 9 and 12
Assessement via self-administered questionnaire: Maternal Antenatal Attachment Scale (MAAS) consists of 19 items which are scored 1-5, with higher scores indicating higher levels of bonding.
between pregnancy week 9 and 12
Mother-child bond
Time Frame: between pregnancy week 23 and 26
Assessement via self-administered questionnaire: Maternal Antenatal Attachment Scale (MAAS) consists of 19 items which are scored 1-5, with higher scores indicating higher levels of bonding.
between pregnancy week 23 and 26
Mother-child bond
Time Frame: between pregnancy week 36 and 39
assessement via self-administered questionnaire: Maternal Antenatal Attachment Scale (MAAS) consists of 19 items which are scored 1-5, with higher scores indicating higher levels of bonding.
between pregnancy week 36 and 39
Sociodemographics
Time Frame: between pregnancy week 9 and 12
age, education (</=/> school years), partnership, employment status
between pregnancy week 9 and 12
Left ventricular muscle mass index
Time Frame: Echocardiography between pregnancy week 9 and 12
Echocardiography will be done by qualified staff.
Echocardiography between pregnancy week 9 and 12
Left ventricular muscle mass index
Time Frame: cardiac ultrasound measurement between pregnancy week 23 and 26
Echocardiography will be done by qualified staff.
cardiac ultrasound measurement between pregnancy week 23 and 26
Left ventricular muscle mass index
Time Frame: Echocardiography between pregnancy week 36 and 39
Echocardiography will be done by qualified staff.
Echocardiography between pregnancy week 36 and 39
Echocardiographic global strain, in %
Time Frame: Echocardiography between pregnancy week 9 and 12
Echocardiography will be done by qualified staff.
Echocardiography between pregnancy week 9 and 12
Echocardiographic global strain, in %
Time Frame: cardiac ultrasound measurement between pregnancy week 23 and 26
The cardiac ultrasound examination will be conduced by qualified staff.
cardiac ultrasound measurement between pregnancy week 23 and 26
Echocardiographic global strain, in %
Time Frame: Echocardiography between pregnancy week 36 and 39
Echocardiography will be done by qualified staff.
Echocardiography between pregnancy week 36 and 39

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sabina Ulbricht, Prof., University Medicine Greifswald, Dep.Social Medicine and Prevention

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 25, 2020

Primary Completion (Actual)

May 30, 2022

Study Completion (Actual)

May 30, 2022

Study Registration Dates

First Submitted

June 17, 2020

First Submitted That Met QC Criteria

August 24, 2020

First Posted (Actual)

August 26, 2020

Study Record Updates

Last Update Posted (Estimated)

December 8, 2023

Last Update Submitted That Met QC Criteria

December 7, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • BB002/20

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Activity

Clinical Trials on Accelerometry

3
Subscribe